MD Anderson Announces Collaboration with Johnson & Johnson Innovation on cancer immunotherapy
The University of Texas MD Anderson Cancer Center will collaborate with
Johnson & Johnson Innovation, LLC, and its affiliate Janssen
Biotech, Inc., to develop immunology-based cancer treatments through the
MD Anderson Moon Shots Program immunotherapy platform.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news